Goldman Sachs’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Buy |
341,641
+228,695
| +202% | +$3.66M | ﹤0.01% | 2730 |
|
|
2025
Q1 | $2.19M | Sell |
112,946
-149,240
| -57% | -$2.9M | ﹤0.01% | 3306 |
|
|
2024
Q4 | $5.78M | Sell |
262,186
-125,964
| -32% | -$2.77M | ﹤0.01% | 2748 |
|
|
2024
Q3 | $6.54M | Sell |
388,150
-957,661
| -71% | -$16.1M | ﹤0.01% | 2574 |
|
|
2024
Q2 | $16.1M | Buy |
1,345,811
+810,221
| +151% | +$9.68M | ﹤0.01% | 1730 |
|
|
2024
Q1 | $5.93M | Buy |
535,590
+239,816
| +81% | +$2.66M | ﹤0.01% | 2440 |
|
|
2023
Q4 | $2.56M | Buy |
295,774
+199,107
| +206% | +$1.72M | ﹤0.01% | 3056 |
|
|
2023
Q3 | $740K | Buy |
96,667
+77,508
| +405% | +$593K | ﹤0.01% | 3693 |
|
|
2023
Q2 | $138K | Sell |
19,159
-111,516
| -85% | -$803K | ﹤0.01% | 4503 |
|
|
2023
Q1 | $796K | Buy |
130,675
+96,133
| +278% | +$585K | ﹤0.01% | 3818 |
|
|
2022
Q4 | $151K | Sell |
34,542
-16,196
| -32% | -$70.6K | ﹤0.01% | 4583 |
|
|
2022
Q3 | $199K | Buy |
50,738
+26,407
| +109% | +$104K | ﹤0.01% | 4723 |
|
|
2022
Q2 | $124K | Buy |
24,331
+563
| +2% | +$2.87K | ﹤0.01% | 5056 |
|
|
2022
Q1 | $152K | Buy |
23,768
+1,717
| +8% | +$11K | ﹤0.01% | 5187 |
|
|
2021
Q4 | $177K | Buy |
+22,051
| New | +$177K | ﹤0.01% | 5039 |
|